Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q2 2025 Earnings Call Transcript August 5, 2025
Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.75 EPS, expectations were $-0.66.
Operator: Good day, and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Dave...
